con®rming an organic basis for their erectile dysfunction. Patients underwent cavernosal blood gas analysis during duplex ultrasonography or DICC, 10 ± 15 min after injection of PGE1 or tri-mix.
They found a signi®cant higher intracavernosal PO2 in the VOD patients than arteriogenic ED patients. However,`men with severe venous leak impotence' had PO2 values higher than arteriogenic group but with no statistical meaning. The authors concluded that chronic ischaemia and low cavernosal PO2 could be the mechanism for arteriogenic and severe venogenic impotence'. Mildamoderatè venous leak' should have a different physiological mechanism.
The relationship between intracavernosal low PO2 tension and corporeal ®brosis is well recognized. However may we establish this relation cause-effect based on single blood gas analysis? How reliable is an analysis done 10 ± 15 min after the injection of PGE1 or tri-mix during DICC or duplex-ultrasonography? There are too many variables. This situation can represent only the condition of the test; one can wonder if a better muscle relaxation can lead to different O2 tension.
Cavernometry results of a patient can change according to the drugs used 2 and the situations of the tests. 3 Hatzichristou et al 4 showed that at least two injections were necessary to get maximum muscle relaxation in 85% of patients, thus getting the maximum response after intracavernosal vasoactive drug and changing completely intracavernosal conditions.
One can speculate that if you do the analysis during duplex ultrasonography (less invasive than DICC) you can get a better erectile response, because patient can be less anxious (less needles), and maybe a different intracorporeal environment.
If chronic low O2 tension is responsible for arteriogenic and severe venous leakage, why do mild venous leakage patients have different (higher) O2 tension? Authors proposed a different mechanism, but it is logical to speculate that mild venous leakage should be a lighter situation than severe venous leakage and should precede it. So both situations should have the same origin with different degrees.
Therefore, before we can establish the relationship between cavernosal ®brosis and low PO2 in arteriogenic and VOD patients those blood gas studies should be done under strict conditions and less bias. While a number of studies have explored the pathophysiology of erectile dysfunction (reviewed in refs. 1 and 2), the pathophysiology of Peyronie's disease has remained elusive, in part, due to a lack of experimental models. The paper by Ahuja et al 3 is an interesting report which seeks to establish a cell culture model for this purpose. Peyronie's disease (indurato penis plastica) is an in¯ammatory condition which is characterized by the formation of ®brous, noncompliant nodules within the tunica albuginea. 4 ± 6 These plaques impede tunical expansion during erection resulting in penile bending. One of the most likely causes of Peyronie's disease may be repeated tunical mechanical stress and microvascular trauma in which excessive penile bending during erection results in bleeding into the subtunical spaces or tunical delamination at the point where the septum integrates into the inner circular layer of the tunica albuginea. 4 ± 6 Oxidative damage has also been proposed to be key in the development of Peyronie's disease 3 as well as in the overall pathogenesis of soft tissue ®brosis. 7 The design of relevant experimental models of Peyronie's disease are complicated by the anatomy of the tunica albugenia 8 as well as the complexity of the wound healing response. Wound healing involves a number of different cell types including neutrophils, macrophages and (myo)®broblasts. 9 These cell types can modulate each other and themselves via complex paracrine and autocrine mechanisms. 9 The collagenous connective tissue matrix plays a poorly understood role, as neutrophils, macrophages and ®broblasts must migrate through this connective tissue to the wounding site. The ®bro-blasts in the tunica albugenia appear histologically as isolated cells within the connective tissue matrix and not adjacent cells as in the corpus cavernosum smooth muscle. Recently, an animal model of Peyronie's disease has been reported in which intratunical injection of cytomodulin induces an in¯ammatory response followed by increased transforming growth factor-b1 expression and Peyronie'slike plaques. 10, 11 Ahuja et al in this study uses late passage human corpus cavernosum smooth muscle cells which have (de)differentiated into myo®broblasts as an in vitro model for Peyronie's disease. 3 There may be several conceptual and experimental issues with such an approach. While the myo®broblast is an important cell type in wound healing and ®broplasia, 12 few reports in the literature corroborate corpus cavernosum myo®broblast involvement in tunical albugenia plaques in Peyronie's patients. 13, 14 Further research is required to determine if trabecular smooth muscle (de)differentiation into myo®broblasts and migration into the tunica albugenia plays any role in the pathophysiology of Peyronie's disease. Also, due to the isolated histological nature of tunical ®broblasts described above, a con¯uent (myo)®broblast cell culture system may have limited application as a Peyronie's disease model.
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Ahuja et al demonstrate that oxidative stress can enhance collagen synthesis of human corpus cavernosum myo®broblasts in culture. 3 Several experimental issues need to be noted in this paper. The commercial ®brillar collagen antibodies in this study recognize the unique procollagen amino and carboxy termini in types I and III collagen. These ends are proteolyzed by speci®c peptidases during the processing of collagen to a mature form. Thus the authors may detect only newly synthesized collagen. Future studies with western blots of preparations with both pepsinized (mature) and untreated preparations may be useful in de®ning nascent versus total collagen synthesis. Inclusion of b-aminoproprionitrile to inhibit collagen crosslinking also aids in the solubilization and subsequent analysis of individual collagen subtypes (discussed in ref 15) . It should also be noted as the authors cite in their paper that smooth muscle cells show a cell density dependence in collagen subtype expression.
In conclusion, while cell culture studies have shortcomings which most certainly may differ from in vivo pathophysiology, these studies provide a means of dissecting molecular mechanisms a single cell type. Such studies are invaluable in the further design and interpretation of animal model experiments and clinical data as well in the formulation of overall hypotheses of disease. Despite these issues, this is an interesting study which is one of the ®rst to examine the effect of oxidative damage on cultured human corpus cavernosum myo®bro-blasts.
RB Moreland
Reply to RB Moreland
Peyronie's disease is a localized connective tissue disorder characterized by the accumulation of collagen types I and III ®bers in the tunica albuginea of the penis. Until recently, there have been no wellcharacterized in-vitro or in-vivo models to study this perplexing condition. In our recently published study, we document an accumulation of both collagen types I and III ®bers in human cavernosal cells exposed to oxidative stress. We agree that further research is required to elaborate the role of myo®bro-blasts, which are most likely de-differentiated cavernosal smooth muscle cells. Their true contribution to this disease process has yet to be unequivocally established. We have recently developed a cell culture system growing isolated human tunica albugineal ®broblasts, which is conceivably more appropriate to study the molecular mechanisms involved in the pathophysiology of Peyronie's disease. Future studies using Western blot analysis with pepsinized cells will better document the collagen deposition phenomenon. We agree that Peyronie's disease is a result of an in¯ammatory cascade that likely involves an interplay
